AIM 1: To investigate the genes involved in the molecular mechanism that characterize CAN in kidney transplant recipients, we will study gene expression in kidney biopsy samples from patients with CAN. For comparison analysis, we will study gene expression profiling in normal kidney biopsies (Control Group 1).